Custom Antibody Market Share, Trends, Scope, Industry Analysis, Forecast Till 2030: SPER Market Research

Published: Apr 2022	Report ID: BIOT2214	Pages: 1 - 228	Formats^*:
Category : Biotechnology

Global Custom Antibody Market Overview:

According to SPER Market Research, the Custom Antibody Market estimated to reach USD 889.6 million by 2030 with a CAGR of 9.4%. Increasing industry-academia collaborations, growing research activity particularly in the life sciences industry; are the key that impel the market expansion.

Impact of COVID-19 on the Custom Antibody Market

Increase in research activities, availability of funding for research and the demand for antibodies, pharmaceutical companies, and small start-ups, has taken step to develop treatments and vaccines that target the infection. So there is a positive impact in this custom antibody market.

Scope of the report:

Report Metric	Details
Market size available for years	2019-2030
Base year considered	2021
Forecast period	2022-2030
Segments covered	By Type, By Service, By Source, By Research Area, By End-User, By Region
Geographies covered	North America, Europe, Asia Pacific, Latin America, Middle East, Africa
Companies Covered	BioLegend, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., GenScript, Merck Group, Rockland Immunochemicals, Thermo Fisher Scientific, Inc.

Driver: growing research activities and funding

Growing research activities and funding, quality concerns over catalogue antibodies, increasing industry-academia collaborations, rising focus on therapeutic antibodies and extensive pipeline drugs; are the key factors that drive the market expansion.

Restraint:

Antibody development is a costly and time consuming process that resists the market expansion.

Opportunity: Increasing demand for personalized medicine in protein therapeutics

Growing demand for personalized medicine in protein therapeutics, rising focus on biomarker discovery, high growth opportunities in developing countries.

Challenges: Presence of Alternative Antibodies

Availability of alternative antibodies in the market that is a challenge to the custom antibody market expansion.

Global Custom Antibody Market Segmentation:

By Type: Based on the Type, Global Custom Antibody Market is segmented as; Monoclonal Antibodies, Other Custom Antibodies, Polyclonal Antibodies, Recombinant Antibodies.

By Service: Based on the Service, Global Custom Antibody Market is segmented as; Antibody Development, Antibody Production & Purification, Antibody Fragmentation & Labeling.

By Source: Based on the Source, Global Custom Antibody Market is segmented as; Mice, Rabbits, Other Sources.

By Research Area: Based on the Research Area, Global Custom Antibody Market is segmented as; Cardiovascular Disease, Immunology, Infectious Diseases, Neurobiology, Oncology, Other Research Areas, Stem Cells.

By End-User: Based on the End-User, Global Custom Antibody Market is segmented as; Academic & Research Institutes, Contract Research organizations, Pharmaceutical & Biotechnology Companies.

By Region: North America owns the biggest share of the Global Custom Antibody Market; this is because of increasing research in the fields of genomics and proteomics, antibody-based therapeutics. The growing investments in the development of structure-based drug designs, and growing demand for high-quality research tools for data reproducibility.

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1 Research data source

2.1.1 Secondary data
2.1.2 Primary data
2.1.3 SPERâ€™s internal database
2.1.4 Premium insight from KOLâ€™s

2.2 Market size estimation

2.2.1 Top-down and Bottom-up approach

2.3 Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis

4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges

4.2. COVID-19 Impacts of the Custom Antibody Market

5. Market variables and outlook

5.1. SWOT analysis

5.1.1 Strengths
5.1.2 Weaknesses
5.1.3 Opportunities
5.1.4 Threats

5.2. PESTEL analysis

5.2.1 Political landscape
5.2.2 Economic landscape
5.2.3 Social landscape
5.2.4 Technological landscape
5.2.5 Environmental landscape
5.2.6 Legal landscape

5.3. PORTERâ€™S five forces analysis

5.3.1 Bargaining power of suppliers
5.3.2 Bargaining power of Buyers
5.3.3 Threat of Substitute
5.3.4 Threat of new entrant
5.3.5 Competitive rivalry

5.4. Heat map analysis

6. Global Custom Antibody Market, By Type, 2019-2030 (USD Million)

6.1. Monoclonal Antibodies
6.2. Other Custom Antibodies
6.3. Polyclonal Antibodies
6.4. Recombinant Antibodies

7. Global Custom Antibody Market, By Service, 2019-2030 (USD Million)

7.1. Antibody Development
7.2. Antibody Production & Purification
7.3. Antibody Fragmentation & Labeling

8. Global Custom Antibody Market, By Source, 2019-2030 (USD Million)

8.1. Mice
8.2. Rabbits
8.3. Other Sources

9. Global Custom Antibody Market, By Research Area, 2019-2030 (USD Million)

9.1. Cardiovascular Disease
9.2. Immunology
9.3. Infectious Diseases
9.4. Neurobiology
9.5. Oncology
9.6. Other Research Areas
9.7. Stem Cells

10. Global Custom Antibody Market, By End-User, 2019-2030 (USD Million)

10.1. Academic & Research Institutes
10.2. Contract Research organizations
10.3. Pharmaceutical & Biotechnology Companies

11. Global Custom Antibody Market, By Region, 2019-2030 (USD Million)

11.1. North America

11.1.1. United States
11.1.2. Canada
11.1.3. Mexico

11.2. Europe

11.2.1. Germany
11.2.2. United Kingdom
11.2.3. France
11.2.4. Italy
11.2.5. Spain
11.2.6. Rest of Europe

11.3. Asia-Pacific

11.3.1. China
11.3.2. Japan
11.3.3. India
11.3.4. Australia
11.3.5. South Korea
11.3.6. Rest of Asia-Pacific

11.4. South America

11.4.1. Brazil
11.4.2. Argentina
11.4.3. Rest of South America

11.5. Middle East & Africa

11.5.1. Kingdom of Saudi Arabia
11.5.2. United Arab Emirates
11.5.3. Rest of Middle East & Africa

12. Company Profiles

12. 1. BioLegend

12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments

12.2. Bio-Rad Laboratories, Inc.
12.3. Cell Signaling Technology, Inc.

12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments

12.4. GenScript

12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments

12. 5. Merck Group

12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments

12. 6. Rockland Immunochemicals

12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments

12. 7. Thermo Fisher Scientific, Inc

12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary
12.7.4. Recent developments

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1